It works by activating GLP-1 receptors that help regulate appetite, blood sugar levels, and feelings of fullness after eating
[1] Pharmacokinetic modeling with modern LC-MS/MS assays shows that intranasal delivery produces highly variable but measurable plasma exposure, with peak levels in 15-45 minutes and an apparent half-life of roughly 30 minutes, suggesting rapid systemic clearance and emphasizing the importance of titrating dose to symptom window
Egr-1 Transcription Pathway : Early Growth Response gene 1 (Egr-1), activated by BPC-157, acts as a master switch for genes governing cell growth, survival, and blood vessel formation
The relationship between the decline HbA1c and BMI level as a result of applied GLP-1 analogues treatment and study parameters was analysed using multivariable regression analysis
Supplementary information Slideset of figures (download PPTX (PPTX 756 kb) Rights and permissions Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made
You can't supplement your way around a suppressed hypothalamic-pituitary axis